Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-16ONC144JOHN OYLER plan to sell securities of BeOne Medicines Ltd. under Form 144MEDIUM
JOHN OYLER filed Form 144 to notify SEC of plan to sell 3693 units of BeOne Medicines Ltd. securities around 2026-06-16, with aggregate market value of $980,686.49. The total outstanding units is 54885669.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months ...
Mega CapBiotechnology
2026-06-16ABOS144DERRELL PORTER plan to sell securities of ACUMEN PHARMACEUTICALS, INC. under Form 144MEDIUM
DERRELL PORTER filed Form 144 to notify SEC of plan to sell 12800 units of ACUMEN PHARMACEUTICALS, INC. securities around 2026-06-16, with aggregate market value of $29,767.68. The total outstanding units is 72227580.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in pa...
Micro CapBiotechnology
2026-06-16NKTR144ROBIN HOWARD W plan to sell securities of NEKTAR THERAPEUTICS under Form 144MEDIUM
ROBIN HOWARD W filed Form 144 to notify SEC of plan to sell 10000 units of NEKTAR THERAPEUTICS securities around 2026-06-16, with aggregate market value of $609,600.00. The total outstanding units is 33786032.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3 mon...
Mid CapBiotechnology
2026-06-16ADPT144Harlan Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Harlan Robins filed Form 144 to notify SEC of plan to sell 6160 units of Adaptive Biotechnologies Corporation securities around 2026-06-16, with aggregate market value of $106,075.20. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactio...
Mid CapBiotechnology